Literature DB >> 17050606

Proliferative capacity of epitope-specific CD8 T-cell responses is inversely related to viral load in chronic human immunodeficiency virus type 1 infection.

Cheryl L Day1, Photini Kiepiela, Alasdair J Leslie, Mary van der Stok, Kriebashne Nair, Nasreen Ismail, Isobella Honeyborne, Hayley Crawford, Hoosen M Coovadia, Philip J R Goulder, Bruce D Walker, Paul Klenerman.   

Abstract

The relationship between the function of human immunodeficiency virus (HIV)-specific CD8 T-cell responses and viral load has not been defined. In this study, we used a panel of major histocompatibility complex class I tetramers to examine responses to frequently targeted CD8 T-cell epitopes in a large cohort of antiretroviral-therapy-naïve HIV type 1 clade C virus-infected persons in KwaZulu Natal, South Africa. In terms of effector functions of proliferation, cytokine production, and degranulation, only proliferation showed a significant correlation with viral load. This robust inverse relationship provides an important functional correlate of viral control relevant to both vaccine design and evaluation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17050606      PMCID: PMC1797250          DOI: 10.1128/JVI.01754-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors.

Authors:  Stephen A Migueles; Alisha C Laborico; W Lesley Shupert; M Shirin Sabbaghian; Ronald Rabin; Claire W Hallahan; Debbie Van Baarle; Stefan Kostense; Frank Miedema; Mary McLaughlin; Linda Ehler; Julia Metcalf; Shuying Liu; Mark Connors
Journal:  Nat Immunol       Date:  2002-10-07       Impact factor: 25.606

2.  Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation.

Authors:  Michael R Betts; Jason M Brenchley; David A Price; Stephen C De Rosa; Daniel C Douek; Mario Roederer; Richard A Koup
Journal:  J Immunol Methods       Date:  2003-10-01       Impact factor: 2.303

3.  High viral burden in the presence of major HIV-specific CD8(+) T cell expansions: evidence for impaired CTL effector function.

Authors:  S Kostense; G S Ogg; E H Manting; G Gillespie; J Joling; K Vandenberghe; E Z Veenhof; D van Baarle ; S Jurriaans; M R Klein; F Miedema
Journal:  Eur J Immunol       Date:  2001-03       Impact factor: 5.532

4.  Impaired function of circulating HIV-specific CD8(+) T cells in chronic human immunodeficiency virus infection.

Authors:  P Shankar; M Russo; B Harnisch; M Patterson; P Skolnik; J Lieberman
Journal:  Blood       Date:  2000-11-01       Impact factor: 22.113

5.  PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression.

Authors:  Cheryl L Day; Daniel E Kaufmann; Photini Kiepiela; Julia A Brown; Eshia S Moodley; Sharon Reddy; Elizabeth W Mackey; Joseph D Miller; Alasdair J Leslie; Chantal DePierres; Zenele Mncube; Jaikumar Duraiswamy; Baogong Zhu; Quentin Eichbaum; Marcus Altfeld; E John Wherry; Hoosen M Coovadia; Philip J R Goulder; Paul Klenerman; Rafi Ahmed; Gordon J Freeman; Bruce D Walker
Journal:  Nature       Date:  2006-08-20       Impact factor: 49.962

6.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

Authors:  R A Koup; J T Safrit; Y Cao; C A Andrews; G McLeod; W Borkowsky; C Farthing; D D Ho
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

7.  Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.

Authors:  P Borrow; H Lewicki; B H Hahn; G M Shaw; M B Oldstone
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

8.  Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children.

Authors:  P J Goulder; Y Tang; C Brander; M R Betts; M Altfeld; K Annamalai; A Trocha; S He; E S Rosenberg; G Ogg; C A O'Callaghan; S A Kalams; R E McKinney; K Mayer; R A Koup; S I Pelton; S K Burchett; K McIntosh; B D Walker
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

9.  HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function.

Authors:  V Appay; D F Nixon; S M Donahoe; G M Gillespie; T Dong; A King; G S Ogg; H M Spiegel; C Conlon; C A Spina; D V Havlir; D D Richman; A Waters; P Easterbrook; A J McMichael; S L Rowland-Jones
Journal:  J Exp Med       Date:  2000-07-03       Impact factor: 14.307

10.  Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells.

Authors:  Mathias Lichterfeld; Daniel E Kaufmann; Xu G Yu; Stanley K Mui; Marylyn M Addo; Mary N Johnston; Daniel Cohen; Gregory K Robbins; Eunice Pae; Galit Alter; Alysse Wurcel; David Stone; Eric S Rosenberg; Bruce D Walker; Marcus Altfeld
Journal:  J Exp Med       Date:  2004-09-20       Impact factor: 14.307

View more
  53 in total

1.  Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine.

Authors:  Saravana K Kanagavelu; Victoria Snarsky; James M Termini; Sachin Gupta; Suzanne Barzee; Jacqueline A Wright; Wasif N Khan; Richard S Kornbluth; Geoffrey W Stone
Journal:  Vaccine       Date:  2011-12-04       Impact factor: 3.641

Review 2.  The quest for a T cell-based immune correlate of protection against HIV: a story of trials and errors.

Authors:  Richard A Koup; Barney S Graham; Daniel C Douek
Journal:  Nat Rev Immunol       Date:  2010-12-17       Impact factor: 53.106

3.  CD8 T-cell proliferative capacity is compromised in primary HIV-1 infection.

Authors:  Sonya L Heath; Steffanie Sabbaj; Anju Bansal; J Michael Kilby; Paul A Goepfert
Journal:  J Acquir Immune Defic Syndr       Date:  2011-03-01       Impact factor: 3.731

4.  Differential impact of magnitude, polyfunctional capacity, and specificity of HIV-specific CD8+ T cell responses on HIV set point.

Authors:  Catherine Riou; Wendy A Burgers; Koleka Mlisana; Richard A Koup; Mario Roederer; Salim S Abdool Karim; Carolyn Williamson; Clive M Gray
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

5.  Epitope specificity delimits the functional capabilities of vaccine-induced CD8 T cell populations.

Authors:  Brenna J Hill; Patricia A Darrah; Zachary Ende; David R Ambrozak; Kylie M Quinn; Sam Darko; Emma Gostick; Linda Wooldridge; Hugo A van den Berg; Vanessa Venturi; Martin Larsen; Miles P Davenport; Robert A Seder; David A Price; Daniel C Douek
Journal:  J Immunol       Date:  2014-10-27       Impact factor: 5.422

6.  Initial viral load determines the magnitude of the human CD8 T cell response to yellow fever vaccination.

Authors:  Rama S Akondy; Philip L F Johnson; Helder I Nakaya; Srilatha Edupuganti; Mark J Mulligan; Benton Lawson; Joseph D Miller; Bali Pulendran; Rustom Antia; Rafi Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-23       Impact factor: 11.205

7.  High cell-free virus load and robust autologous humoral immune responses in breast milk of simian immunodeficiency virus-infected african green monkeys.

Authors:  Andrew B Wilks; James R Perry; Elizabeth P Ehlinger; Roland C Zahn; Robert White; Marie-Claire Gauduin; Angela Carville; Michael S Seaman; Joern E Schmitz; Sallie R Permar
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

8.  TCR independent suppression of CD8(+) T cell cytokine production mediated by IFNγ in vivo.

Authors:  Martin P Hosking; Claudia T Flynn; J Lindsay Whitton
Journal:  Virology       Date:  2016-08-24       Impact factor: 3.616

9.  Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control.

Authors:  Adam R Hersperger; Florencia Pereyra; Martha Nason; Korey Demers; Prameet Sheth; Lucy Y Shin; Colin M Kovacs; Benigno Rodriguez; Scott F Sieg; Leia Teixeira-Johnson; Debbie Gudonis; Paul A Goepfert; Michael M Lederman; Ian Frank; George Makedonas; Rupert Kaul; Bruce D Walker; Michael R Betts
Journal:  PLoS Pathog       Date:  2010-05-27       Impact factor: 6.823

10.  HIV-specific CD8+ T cells from elite controllers are primed for survival.

Authors:  Jiyu Yan; Steffanie Sabbaj; Anju Bansal; Nilesh Amatya; John J Shacka; Paul A Goepfert; Sonya L Heath
Journal:  J Virol       Date:  2013-02-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.